Compare Revvity Inc (RVTY) vs Tyson Foods, Inc. (TSN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Revvity Inc vs Tyson Foods, Inc. — how do they compare? Revvity Inc trades at $124.14 (market cap $13.82B), while Tyson Foods, Inc. trades at $51.97 (market cap $18.20B). The key difference: Tyson Foods, Inc. is the larger of the two by market cap, and Tyson Foods, Inc. pays the higher dividend (3.94%). Which is the better fit depends on your goals.
| RVTY | TSN | |
|---|---|---|
Market Cap | $13.82B | $18.20B |
Sector | Technology | Consumer Staples |
52-Week High | $130.94 | $68.75 |
52-Week Low | $82.26 | $50.72 |
Enterprise Value | $16.14B | $25.47B |
Dividend Yield | 0.23% | 3.94% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
RVTY trades at $127.08, down 2.41% on the day, with a bullish technical signal from moving averages and strong support at $126. The company reported Q2 2026 EPS of $1.41, beating estimates, and raised its full-year outlook, driven by diagnostics strength and improved cash flow. Recent news includes the acquisition of Human Cell Design and the launch of the SuperFlex prenatal screening system.
Outlook is positive with 52% analyst buy ratings and a $135.25 consensus price target, implying ~6% upside. Risks include a premium valuation (P/E 61.1) and execution of growth initiatives. Strong institutional interest, such as Bank of New York Mellon's $78.77 million investment, supports confidence in the stock's trajectory.
Tyson Foods (TSN) trades at $52.28, up 1.67% today, with mixed technical signals showing bearish moving averages but oversold RSI levels. Fundamentally, the company reported Q2 2026 EPS of $0.99 beating expectations, though revenue growth guidance was recently cut to 1.5%-2.0% for fiscal 2026 due to beef segment pressures. Valuation metrics show a P/E of 32.27 and P/S of 0.33, with analyst consensus leaning bullish despite recent negative news flow.
The stock presents a contrarian opportunity with oversold technical conditions and positive analyst targets averaging $69, but faces significant headwinds from operational challenges in the beef business and ongoing legal investigations. Investors must weigh the attractive valuation multiples against execution risks and margin pressures in the current operating environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →About Tyson Foods, Inc.
Tyson Foods is the largest U.S. producer of processed chicken and beef. It's also a large producer of processed pork and protein-based products under the brands Jimmy Dean, Hillshire Farm, Ball Park, Sara Lee, Aidells, State Fair, and Raised & Rooted, to name a few. Tyson sells 81% of its products through various U.S. channels, including retailers (47% in fiscal 2021), food service (32%), and other packaged food and industrial companies (10%). In addition, 11% of the company's revenue comes from exports to Canada, Mexico, Brazil, Europe, China, and Japan.
Read more on TSN →
